
By combining the fully biodegradable and biocompatible MediVas polymers with the Pfizer compounds, MediVas and Pfizer hope to create a product that can change the paradigm of how ophthalmic treatments are administered.
No financial terms of the agreement were disclosed.
Find more details from the press release.






Comment Preview